mechanism exists in Xenopus and has been conserved Results for regulating the activity of Chordin in the Spemann Xolloid mRNA Ventralizes Ectoderm and Mesoderm organizer. For this purpose, we used a Xenopus tolloidTo test the hypothesis that Xolloid might inactivate like gene called Xolloid (Goodman et al., 1997) . Xolloid Chordin, we first investigated whether Xolloid microinwas chosen because, like BMP-4, it has a strong venjection could mimic the effects of chordino loss-of-functralizing activity in Xenopus animal cap explants, in tion in zebrafish. Xolloid mRNA was injected into four which it is able to override the dorsalizing effects of blastomeres at the 4-or 8-cell stage (radial injections) activin, leading to the formation of blood and ventral of Xenopus development, and the resulting embryos mesoderm, as BMP-4 does (Dale et al., 1992; Jones et were analyzed by whole-mount in situ hybridization. Goodman et al., 1997) . In the Xenopus embryo, the gastrula/neurula stage, a considerable reduction of Xolloid mRNA accumulates in oocytes and unfertilized the neural domain (marked by Sox-2 and Slug) was obeggs, and levels are maintained through early developserved in the ectoderm (Figures 1A and 1B) . Markers ment until the start of neurulation (Goodman et al., 1997) .
of dorsal mesoderm were also reduced by injection of At these stages, the Xenopus embryo also expresses Xolloid (sonic hedgehog and MyoD, Figures 1C and 1D ), significant amounts of BMP-2, BMP-4, and BMP-7 (Dale while a ventral mesodermal marker was expanded et Nishimatsu et al., 1992; (Xwnt-8, Figure 1F ). Despite the strong ventralization and Thomsen, 1995) . Therefore, Xolloid and BMPs are revealed by these early markers, by the swimming tadcoexpressed during early development. Although Xolpole stage (3 days) similarly injected embryos recovered loid transcripts appear to be uniformly distributed at to a considerable extent ( Figure 1I ). However, these tadthese early stages, at the tailbud stage Xolloid tranpoles still had reduced heads and CNS, the notochord scripts are found in the tail periphery surrounding the was frequently absent, somites were reduced, and conchordin-expressing cells of the chordoneural hinge comitantly, an increased amount of ventral blood islands (B. L., unpublished data). Thus, Xolloid is expressed at were observed in histological sections (data not shown). the right time in development to possibly interact with This recovery of axial structures was reminiscent of Chordin and BMPs.
the case of the chordino mutation in zebrafish, which The overall structure of Xolloid is very similar to that has severe reductions of dorsal ectodermal and mesoof tolloid, with a metalloprotease domain followed by dermal markers at the gastrula stage but undergoes an interaction domain composed of two EGF and five a remarkable recovery by the end of embryogenesis C1r/s repeats. In the mouse, two related genes have (Hammerschmidt et al., 1996a (Hammerschmidt et al., , 1996b . In addition, in been isolated, tolloid-like (mtll) and mBMP-1. mtll has chordino mutants, expression of BMP-4 is increased an overall structure similar to that of Xolloid and tolloid (Hammerschmidt et al., 1996b) and, although chordino , although it is unclear at present mRNA is initially expressed normally, its transcription whether it is a Xolloid homolog. A similar structure is collapses in the organizer at mid-gastrula stages (Schultealso found in a spliced form of BMP-1, while a shorter Merker et al., 1997) . Thus, the loss of Chordin-BMP form lacks one EGF and two C1r/s repeats. Both forms antagonism in the extracellular space is potentiated by have been shown to process the C terminus of fibrillar a feedback loop that leads to activation of BMP transprocollagens (Kessler et al., 1996) . In contrast to Xolloid, cription and repression of chordino transcription (Schultethe short-form of Xenopus BMP-1 is unable to mimic Merker et al., 1997) . Interestingly, radial Xolloid mRNA the blood-inducing activity of BMP-4 in activin-treated injections result in a similar expansion of BMP-4 expresanimal caps (Goodman et al., 1997; Maé no et al., 1993) , sion ( Figure 1F ) and in the lack of maintenance of chordin and the long form is reported to dorsalize ventral mesoexpression at mid-gastrula stages (compare Figures 1G derm (Lin et al., 1997) . Taken together, the biological and 1H). activity in animal caps, the expression in the early emThese results indicate that overexpression of the Xolbryo, and the structural similarities suggested that Xolloid secreted protease results in the loss of dorsal ectoloid was the best candidate to mediate a tolloid-like dermal and mesodermal tissues at the gastrula stage. activity in Xenopus.
The similarities with the zebrafish chordino mutant sugIn this study, we present data showing that in mRNA gest that the effect of Xolloid overexpression in Xenopus microinjection assays, Xolloid acts upstream of BMP is to partially antagonize the dorsalizing role of organizer receptor signaling, blocking the effects of chordin but signals. not those of noggin or follistatin. In biochemical studies, soluble Xolloid protein has protease activity, cleaving chordin at two specific sites and inactivating its BMP Xolloid Inactivates Chordin antagonizing activity. Digestion of an inactive complex Ventralization by Xolloid mimics the effects of injection of BMPs and Chordin with Xolloid results in the recovery of low doses of BMP-4 (Dale et al., 1992; Jones et al., of BMP biological activity. Experiments with a dominant-1992) . To test whether Xolloid functions through the negative point mutation in Xolloid indicate that the Xol-BMP pathway, Xolloid mRNA was injected together with loid protease activity is required in vivo for correct dora dominant-negative BMP receptor (DNBMPR) that mimsoventral patterning in Xenopus. Taken together, the ics organizer activity, causing the formation of secondresults suggest a novel mechanism for regulating the ary axes after microinjection into ventral blastomeres at activity of Spemann's organizer mediated by a proteothe 4-cell stage (Graff et al., 1994; Suzuki et al., 1994) . Xolloid mRNA had no effect on these secondary dorsal lytic step. found to block secondary axis induction by chordin (I) Normal (top) and XLD-injected 3-day tadpoles (bottom). Embryos mRNA (compare Figures 2C and 2D ), but had no effect were injected radially with 200 pg of XLD mRNA in each blastomere at the 4-cell stage. Note the recovery to a relatively mild ventralizaon secondary axes induced by noggin or follistatin (Fig- tion (93% affected, DAI ϭ 3.2, n ϭ 311) when compared with the ures 2E and 2F). The observation that Xolloid is specific severe reduction in axial and neural markers observed at the early for chordin is of particular importance regarding the stages.
sequence similarities found between Xolloid and BMP-1. Mammalian BMP-1 is a procollagen processing protease (Kessler et al., 1996; Suzuki et al., 1996) , and a case axes, indicating that Xolloid requires an active BMP pathway to exert its ventralizing activity (Figures 2A and 2B) .
could have been made for the ventralizing effects of Xolloid being mediated by proteolytic modifications of the extraThree dorsalizing factors, Chordin, Noggin, and Follistatin, have been shown to inhibit the BMP pathway by cellular matrix. Because noggin, follistatin, or DNBMPR secondary axes were not affected by Xolloid injection, and because a dominant-negative Xolloid construct dorsalized the embryo (see below), the ventralizing effect cannot be due to nonspecific changes in the matrix. Although one cannot exclude the existence of additional, as yet undiscovered, substrates of Xolloid, the present results indicate that the Xolloid protease acts through Chordin.
Xolloid Cleaves Chordin
To test whether Xolloid inactivates Chordin by proteolysis, a biochemical approach was taken. Xolloid enzyme was prepared by transfection of the 293T human kidney cell line with a Xolloid construct tagged at its C terminus with a Flag epitope. A day after transfection, the cells were placed under serum-free conditions (in medium containing Zn) for 48 hr. The conditioned medium contained two bands in Western blots, a weak one of 150 kDa corresponding to the unprocessed proenzyme, and a stronger band at 130 kDa, a size consistent with that of the processed form lacking the amino-terminal proregion ( Figure 3A , lane 2). Processing is an absolute requirement for the activity of astacin family zymogens (Stocker et al., 1995) . Conditioned medium from cells transfected with DNA vector alone was used as a negative control throughout this study and found to be devoid of activity ( Figure 3 , lane 1). When the Xolloid enzyme was incubated with baculovirus-derived Chordin tagged in the carboxyl terminus with Myc epitope (Piccolo et al., 1996) , a cleaved product was detected ( Figure 3B , lane 2). To determine whether this cleavage was caused by the secreted Xolloid enzyme, a range of protease inhibitors was added, and only the Zinc chelator orthophenantroline was found to be effective ( Figure 3B , lanes 3 and 4). Furthermore, we introduced a point mutation in the Xolloid protease domain in a conserved tyrosine affected in the tolloid antimorphic allele tld 6P4 (Childs and O'Connor, 1994; Finelli et al., 1994) . Structural studies in the Astacin family of metalloproteases (reviewed by Stocker et al., 1995) predict this residue to be dispensable for Zn binding and folding of the protease domain, but crucial for its catalytic activity. This protein, designated as dominant- cleaves CHD at two sites. Lane 3, before addition of Xolloid, CHD conditioned medium is devoid of cleaving activity; lane 2, Xolloidwas preincubated for 2 hr at 25ЊC with a 5 molar excess of recombicontaining medium specifically cleaves CHD, removing an NH 2-ternant human BMP-4, to cause the formation of CHD/BMP-4 comminal fragment; lane 3, Xolloid is inactivated by incubation with 1-10 plexes. ortophenanthroline, an inhibitor of zinc metalloproteases; lane 4, (F) Noggin protein is not cleaved by Xolloid. Lanes 1, 2, and 3 are Xolloid retains enzyme activity in the presence of a protease inhibitor Noggin in control medium, Noggin in Xolloid medium, and Xolloid cocktail that does not affect metalloproteases but should block medium with Noggin-BMP-4 complexes, respectively. serine, aspartic, and cysteine proteases (see Experimental ProceAcrylamide percentages in the SDS-PAGE gels were as follow: (A) dures for details); lane 5, the DN-Xld point mutation is catalytically and (B) 7%; (C) 6%-18% gradient; (D-F) 7.5%-18% gradient. For inactive; lane 6, CHD-Myc protein used as substrate for purified samples in gel (E), the incubation time was extended to 16 hr.
consistent with two cleavage sites, one occurring just after the first cysteine-rich repeat (CR1), and another located within CR3 ( Figures 3C and 3D ). The two cleavages were confirmed by an internal anti-Chordin antibody (␣I, newly derived here, see Experimental Procedures), which revealed that under more complete digestion conditions, most of the Chordin protein remained as an 85 kDa fragment lacking the amino-and carboxy-terminal fragments ( Figure 3E ). Importantly, Chordin precomplexed for 2 hr with a 2-10 molar excess of BMP-4, in conditions in which all Chordin biological activity is blocked (Piccolo et al., 1996) , was an equally good substrate for the Xolloid enzyme ( Figures 3C-3E , lane 3). The Xolloid protease was completely inactive on a HA-tagged noggin substrate ( Figure 3F ), in agreement with the mRNA coinjection results ( Figure 2E ). We conclude that both Chordin and the Chordin/BMP complex are cleaved by the Xolloid metalloprotease at two defined sites.
Cleaved Chordin Protein Is Inactive
Having shown biochemically that Chordin is a substrate for Xolloid, we next tested whether the cleavage inactivated the biological activities of Chordin using ventral marginal zone (VMZ) and animal cap explants. Chordin protein (2 nM final concentration) was digested in vitro with Xolloid conditioned medium to obtain nearly complete cleavage. Untreated VMZ explants rounded up forming ventral mesoderm, but elongated when treated (Hazama et al., 1995; Suzuki et al., 1997) . Xolloid condi-0.7 nM BMP-4/7 preincubated for 2 hr at 25ЊC with, respectively, tioned medium alone was devoid of activity in this assay CHD, CHD cleaved by XLD, and CHD incubated in control medium.
(data not shown). Addition of 0.7 nM BMP-4/7 activated Note that Chordin preincubated with Xolloid is unable to block BMP the ventral marker Xhox3, and 1 nM Chordin prevented signaling. this activation ( Figure 4E, lanes 2 and 3) . However, the same concentration of cleaved Chordin had lost its abillane 5). In addition, purified Xolloid enzyme prepared by ity to antagonize BMP-4/7 ( Figure 4E , lane 4). The results Flag antibody affinity matrix was found to be active on indicate that the cleavage by Xolloid inactivates the antiChordin substrate ( Figure 3B, lanes 6 and 7) . These BMP activity of Chordin. experiments suggest that the cleavage of Chordin is mediated by the Xolloid enzyme and not by other comXolloid Releases Active BMP from ponents present in the conditioned medium.
Chordin/BMP Complexes To map the sites at which Chordin is cleaved by XolTo test whether Xolloid digestion is able to release active loid, we analyzed the digestion products with three difBMPs from inactive Chordin/BMP complexes, we used ferent antibodies. An anti-amino peptide antibody (Pican established assay for BMP activity. This assay is very colo et al., 1996) detected, in addition to the undigested sensitive, permitting detection of BMP activity in the 120 kDa Chordin band, two bands of 19.5 and 102 kDa subnanomolar range, at levels lower than those of any ( Figure 3C ), while the carboxy-terminal Myc tag identicurrent biochemical method. Wilson and Hemmati-Brivanfied two bands of 96 and 16 kDa ( Figure 3D ). These lou (1995) found that BMP-4 is able to prevent the autoneuralization caused by dispersal of the inner layer of the data with antibodies specific for the two termini are a residue that is conserved in the Xolloid protein ( Figure  6A ). The same Tyr-to-Asn point mutation was introduced in Xolloid. The mutant protein was processed and secreted normally ( Figure 3A , lane 3) but was enzymatically inactive on its Chordin substrate ( Figure 3B, lane 5) . Radial injection at the 4-cell stage of mRNA encoding this point mutation (DN-Xld) resulted in dorsalized embryos with enlarged heads and cement glands ( Figure  6D ), whereas wild-type Xld had ventralizing activity (Figure 6C) . The dorsalization caused by DN-Xld affected patterning of the ectodermal and mesodermal germ layers, expanding and increasing the intensity of expression of Sox-2 (neural plate), chordin (organizer and notochord), and MyoD (somitic muscle) markers ( Figures  6E-6G ), as expected from increased Spemann organizer activity.
To demonstrate that DN-Xld can indeed antagonize the activity of wild-type Xld, coinjection and biochemical experiments were carried out. Injection of XLD mRNA into dorsal blastomeres caused ventralization with reduction of head structures ( Figure 6H ), which was rescued by coinjection with a 4-fold excess of DN-Xld (Figure 6I) . For biochemical tests, DN-Xld was cotransfected with Xld into 293T cells and the conditioned medium tested for Chordin cleaving activity. The sample cotransfected with DN-Xld had much reduced enzyme activity when compared to Xolloid alone, although similar amounts of wild-type Xolloid, marked by a HA-epitope tag, were present in both samples ( Figure 6J and data et al., 1997 and Figure 1) . Microinjection of DNBMPR showed that an active BMP pathway is required for ventralization by Xolloid mRNA. The known dorsalizing animal cap. Furthermore, BMP-4 acts as an epidermal (keratin) inducer in this assay. In our experiments, addifactors that work by inhibiting BMPs, Chordin, Noggin, and Follistatin, were tested in coinjection experiments, tion of 0.7 nM BMP-4/7 was sufficient to prevent autoneuralization and to induce keratin in dispersed animal and Xolloid was found to specifically block the activity of Chordin. Biochemical analyses using Xenopus proteins cap cells ( Figure 5, lane 4) . These activities were blocked by preincubating BMP-4/7 with 1 nM Chordin ( Figure 5 , showed that Chordin, but not Noggin, was a substrate for the Xolloid zinc metalloprotease. Xolloid cleaved lane 5). However, when the animal caps were isolated from embryos injected into the animal pole with Xolloid Chordin at two sites, one located just after CR1 and the other within CR3. These cleavages inactivate the mRNA, BMP activity was restored from the previously inactive Chordin/BMP complex, repressing neural tissue biological activity of Chordin, indicating that Xolloid acts through Chordin. It should be noted, however, that our and inducing keratin ( Figure 5, lane 6) By using a sensitive dissociation/reaggregation animal cap assay, we were able to show that cleavage by Xolloid of an inactive Chordin/BMP-4/7 complex results in the release of BMP antineuralizing and epidermisinducing activity ( Figure 5 ). The digestion of Chordin/ BMP complexes by a metalloprotease provides a novel mechanism by which a latent growth factor, rendered inactive by binding to an extracellular antagonist, can be reactivated at particular locations. If the Chordin/ BMP complex were diffusible, this mechanism could facilitate the transport and redistribution of BMPs as has been proposed for SOG/DPP (Holley et al., 1996) . In Drosophila, it is clear that the sog product must be diffusible over long distances, because mosaic studies have shown that sog is required in ventral ectoderm for the formation of the dorsal-most tissue (Zusman et al., 1988) . The biochemical and biological data show that Xolloid can proteolytically inactivate Chordin; thus, the ventralization caused by Xolloid seems to act through a double inhibition mechanism involving Chordin:
Xolloid Is Required for D-V Patterning
A dominant-negative Xolloid (DN-Xld) was generated by introducing a point mutation previously identified in a Drosophila tolloid antimorphic allele (Childs and O'Connor, 1994; Finelli et al., 1994) , and overexpression throughout the embryo resulted in expanded dorsal structures in both ectoderm and mesoderm. This reversal of the Xolloid mRNA ventralizing phenotype by a dominant-negative construct suggests that the normal fection inhibits the enzymatic activity of Xolloid on Chordin sub-(I) Normal development is restored by coexpression of XLD mRNA strate.
In Situ Hybridization and RT-PCR
proteins has been conserved (Holley et al., 1995; Whole-mount in situ hybridizations were carried out according to . Our results suggest that an Harland's method (Harland, 1991) by RT-PCR, using conditions and primers previously described in tation identified in the original Heidelberg screen for Sasai et al. (1995) for testing CHD activity, in Suzuki et al. (1997) for Xhox3, and in Wilson and Hemmati-Brivanlou (1995) for the dissociazygotic mutations in the third chromosome of Drosophtion-reaggregation experiments.
ila (Jü rgens et al., 1984) permitted the construction of the dominant-negative form of Xolloid used in this study.
Protein Expression and Purification
It is remarkable that the mechanisms of dorsoventral are not expressed in graded fashion (Ferguson and An-(Amicon) . Concentrated media were then dialyzed against 10 mM derson, 1992b; Wharton et al., 1993; Fainsod et al., 1994;  HEPES (pH 7.6), 150 mM NaCl, 2.5 mM CaCl2, 1 mM MgCl2, and 1
Hemmati-Brivanlou and Thomsen, 1995) . Work from M ZnCl2 (buffer A). Aliquots were snap-frozen and stored at Ϫ80ЊC.
Drosophila suggests that the gradient of DPP activity
During this study, we used different preparations of Xolloid (n ϭ 4), control (n ϭ 3), and DN-Xld (n ϭ 2) proteins with similar results.
results in part from the diffusion of SOG (Biehs et al.,
For affinity purification of Xolloid-Flag ( Figure 3B , lane 7), 10 ml 1996; Holley et al., 1996) . It is not known whether Chordin of Xld-Flag conditioned medium received NaCl to 0.5 M and of Brij35 is diffusible in Xenopus, but in view of the patterning to 0.2% final concentrations and was then subjected to affinity defects observed in the chordino mutation in zebrafish purification using a Flag affinity matrix (IBI). Binding was for 2 hr in (Hammerschmidt et al., 1996b; Schulte-Merker et al., batch; washings were in a column with 10 mM HEPES (pH 7.6), 0.5 1997), this remains a distinct possibility. The present for the anti-Myc Western blotting of Figure 3C we used a full-length CHD protein purified by cation exchange chromatography. Briefly, cleared baculovirus medium was loaded in a High S column (Bio-
Experimental Procedures
Rad), washed with 10 mM HEPES (pH 7.6), NaCl 80 mM, and proteins eluted with a linear gradient of 80-1200 mM NaCl in 10 mM HEPES Expression Constructs and Synthetic mRNA Preparation (pH 7.6). Full-length undegraded Chordin eluted around 0.8 M NaCl. Full-length Xld DNA (GenBank accession number Y09660) was exFor protease inhibition studies, we used 1 mM 1-10 orthophenancised with EcoRI-DraIII and subcloned in the EcoRI-StuI sites of throline (a Zn metalloprotease inhibitor) and a cocktail of 1 mM pCS2 to generate pCS2-Xld. A Flag-tagged version of Xld was de-PMSF, 10 M Pepstatin, and 1 mM E64 that inhibit, respectively, rived by PCR by inserting the sequence DYKDDDDK-Stop after the serine, aspartic, and cysteine proteases. last amino acid of Xolloid. mRNA prepared from the resulting plasmid (pCS2-Xld-Flag) had indistinguishable activity from Xld mRNA Antibodies and Western Blotting lacking the tag (ventralization 88%, n ϭ 52). Xld-HA was derived For Western blotting, protein samples were resolved under reducing by a similar procedure. Dominant-negative Xld contains a point conditions by SDS-PAGE and electroblotted onto Immobilon P mutation (TAT into AAT) of Tyr-296 into Asn, introduced by a PCR-(Millipore) PVDF membranes. The filters were blocked with 5% powbased approach. After checking the presence of the mutation and dered Carnation milk in TBST and incubated in the same buffer with the fidelity of the amplified DNA by sequencing, a point-mutated 5Ј a 1:500 dilution of all antibodies except for the anti-Internal-CHD EcoRI-SphI fragment was ligated to a wild-type SphI-XbaI Xld-Flag antibody, for which a 1:3000 dilution was used. The ECL luminesfragment into pCS2 to generate pCS2-DN-Xld. For transfection studcence detection kit was from Amersham. Detection of the various ies, Xld-Flag and DN-Xld-Flag sequences were subcloned in the epitope tags was carried out with the following mouse monoclonal EcoRI-XbaI sites of pcDNA3.1. HA-tagged noggin (pcDNA3.1 nogantibodies: anti-myc (Babco), anti-Flag M2 (IBI), and anti-HA gin) was generated by PCR, incorporating the sequence YPYDVP-(Babco). Anti-NH2 CHD peptide antibody was produced as de-DYA-Stop after the last amino acid of noggin. All of these PCR scribed (Piccolo et al., 1996) . For obtaining an anti-Internal-CHD reactions were done with Pfu polymerase (Stratagene) that contains antibody, a CHD peptide (coding from amino acid 592 to 692) was proofreading activity.
expressed in bacteria as a GST fusion protein, purified in a glutathiSynthetic mRNA was prepared using the Message Machine in one column (Pharmacia), and injected into rabbits (Babco). vitro transcription kit (Ambion). For sense mRNAs, pCS2-Xld and pCS2-DN-Xld were linearized with NotI and transcribed with SP6.
Embryological Manipulations DNBMPR, noggin, and follistatin mRNA were synthesized as deVentral marginal zone explants (comprising 60Њ of the VMZ) from stage 10 embryos were prepared in LCMR, opened with an eyebrow scribed in Sasai et al. (1995) .
